SG

Swathi Gadala

Active Director Director DIN 08659263
DIN 08659263 First appointment Jan 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Swathi Gadala

Data last updated:

Swathi Gadala is a Director at Mentriix Clinical Research Private Limited (since 2020). The company operates in Research & Development.

DIN 08659263
Primary Designation Director
Industry Research & Development
First Appointment 06 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jan 20202020Active

Board colleagues of Swathi Gadala

NameDINCompanyDesignation
Bandel Sharmila09769705Mentriix Clinical Research Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Mentriix Clinical Research Private Limited
Premium access

Shareholding and investment profile for Swathi Gadala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swathi Gadala

Swathi Gadala currently holds 1 directorship: Mentriix Clinical Research Private Limited (Director, since 06 Jan 2020).

Swathi Gadala was first appointed on 06 Jan 2020 as Director at Mentriix Clinical Research Private Limited.

The current boards of Swathi Gadala's companies include Bandel Sharmila (Mentriix Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available